Relationship of Campylobacter Toxigenicity In Vitro to the Development of Postinfectious Irritable Bowel Syndrome
Abstract
Campylobacter enteritis is associated with a significant risk of developing irritable bowel syndrome, but the mechanism is unknown. This study ascertained bowel symptoms in 93 patients 3 months after Campylobacter jejuni enteritis infection. The infecting organisms were cultured, and the effects of culture supernatants on toxin-sensitive epithelial cell monolayers (HEp-2, Green monkey kidney epithelial [Vero], and CHO-K1) were investigated. In all, 50, 43, and 41 of the isolates showed toxigenic effects on HEp-2, CHO-K1, and Vero cells, respectively. Persistently changed bowel habit was reported by 9 of 50 persons with HEp-2 toxin-positive infections but by only 2 of 43 with isolates negative for toxin (chi2=4.0; P<.05). Toxicity to HEp-2 and Vero cells was associated with significantly increased numbers of days with loose stools 6 months after C. jejuni enteritis infection (both, P<.05). Thus, long-term symptoms that occur Campylobacter infection are significantly associated with bacterial toxicity.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The strongest risk factors for post-infectious irritable bowel syndrome are bacterial toxicity, prolonged duration of diarrhoea, rectal bleeding and fever.
“in which the strongest risk factors are bacterial toxicity,128 prolonged duration of diarrhoea,124 rectal bleeding129 and fever.125”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Spiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155 · see citing works
Self-citationNeal, K. R., Hebden, J., & Spiller, R. (1997) · BMJ · doi:10.1136/bmj.314.7083.779 · Cited by 586 · see citing works
Self-citationPsychometric scores and persistence of irritable bowel after infectious diarrhoea
Gwee, K., Read, N. W., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., & Walters, S. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90341-4 · Cited by 466 · see citing works
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
Ka, G., Graham, J. C., McKendrick, M. W., Collins, S. M., Marshall, J. S., Walters, S., & Read, N. W. (1996) · African journal of medical practice · Cited by 429 · see citing works
A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp.
Johnson, W. M., & Lior, H. (1988) · Microbial Pathogenesis · doi:10.1016/0882-4010(88)90053-8 · Cited by 275 · see citing works
CHOLERA-LIKE ENTEROTOXIN PRODUCED BY CAMPYLOBACTER JEJUNI
Ruiz-Palacios, G., Torres, N., Ruiz-Palacios, B., et al. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90234-9 · Cited by 217 · see citing works
Toxin production by Campylobacter spp
Wassenaar, T. M. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.466 · Cited by 169 · see citing works
Oomes, P. G., Jacobs, B. C., Hazenberg, M. P., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380208 · Cited by 122 · see citing works
Pathogenic properties of Campylobacter jejuni: assay and correlation with clinical manifestations
Klipstein, F. A., Engert, R. F., Short, H. B., et al. (1985) · Infection and Immunity · doi:10.1128/iai.50.1.43-49.1985 · Cited by 94 · see citing works
Production of a unique cytotoxin by Campylobacter jejuni
Guerrant, R. L., Wanke, C. A., Pennie, R. A., et al. (1987) · Infection and Immunity · doi:10.1128/iai.55.10.2526-2530.1987 · Cited by 79 · see citing works
Eyigör, A., Dawson, K. A., Langlois, B. E., et al. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.5.1646-1650.1999 · Cited by 57 · see citing works
Psychometric scores and persistence of irritable bowel after infectious diarrhoea
King, T. S. (1996) · Clinical Nutrition · doi:10.1016/s0261-5614(96)80040-9 · Cited by 43 · see citing works
Production of enterotoxin and cytotoxin in Campylobacter jejuni strains isolated in Costa Rica
Florin, I., & Antillón, F. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-37-1-22 · Cited by 38 · see citing works
Toxin production by Campylobacter spp.
Wassenaar, T. M. (1997) · Clinical Microbiology Reviews · doi:10.1128/cmr.10.3.466-476.1997 · Cited by 16 · see citing works
Effect of Campylobacter jejuni extracts and culture supernatants on cell culture.
Sq, A., & Huq, F. (1989) · PubMed · Cited by 13 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- Drossman DA, Thompson WG, Talley NJ, Funch-Jensen P, Janssens J, Whitehead WE. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int 1990; 3:159-72.
- Jenkins D, Thornley JP, Wright T, et al. Enterchromaffin and mast cell hyper- plasia parallels mucosal nerve damage following Campylobacter enteritis. Neurogastroenterol Motil 1998; 10:464.
Cited by
Sorted by citations
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024 · see citing works
Self-citationIntestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939 · see citing works
Self-citationGuidelines on the irritable bowel syndrome: mechanisms and practical management
Spiller, R., Aziz, Q., Creed, F., Emmanuel, A., Houghton, L., Hungin, P., Jones, R., Kumar, D., Rubin, G., Trudgill, N., et al. (2007) · Gut · doi:10.1136/gut.2007.119446 · Cited by 818 · see citing works
Self-citationPathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
Öhman, L., & Simrén, M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.4 · Cited by 617 · see citing works
Dunlop, S. P., Jenkins, D., Neal, K. R., & Spiller, R. C. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.028 · Cited by 583 · see citing works
Self-citationTHABANE, M., KOTTACHCHI, D. T., & MARSHALL, J. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03399.x · Cited by 466 · see citing works
Brain–gut connections in functional GI disorders: Anatomic and physiologic relationships
Jones, M. P., Dilley, J. B., Drossman, D., & Crowell, M. D. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2005.00730.x · Cited by 358 · see citing works
Marshall, J. K., Thabane, M., Borgaonkar, M. R., & James, C. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.11.025 · Cited by 241 · see citing works
Role of infection in irritable bowel syndrome
Spiller, R. C. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1925-8 · Cited by 187 · see citing works
Self-citationInfection, inflammation, and the irritable bowel syndrome
Spiller, R., & Garsed, K. (2009) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.07.007 · Cited by 122 · see citing works
Self-citationPorter, C. K., Gormley, R., Tribble, D. R., Cash, B. D., & Riddle, M. S. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.371 · Cited by 111 · see citing works
Grover, M., Camilleri, M., Smith, K., Linden, D. R., & Farrugia, G. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12304 · Cited by 48 · see citing works
- Authors
- Thornley, J. P., Jenkins, D., Neal, K., Wright, T., Brough, J., & Spiller, R. C.
- Affiliations
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-09
- Volume
- 184
- Issue
- 5
- Pages
- 606-609
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2144481594
- Cited by
- 144
- References
- 15
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 6 · 2016: 4 · 2015: 1 · 2014: 12 · 2013: 6 · 2012: 10
- FWCI
- 9.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
- Keywords
- Campylobacter jejuni, post-infectious irritable bowel syndrome, bacterial toxins, enteritis, HEp-2 cells, Vero cells, CHO-K1 cells, loose stools
- MeSH terms
- Adolescent, Adult, Animals, Bacterial Toxins, Campylobacter Infections, Cell Line, Chlorocebus aethiops, Colonic Diseases, Functional, Enteritis, Epithelial Cells, Cricetinae, Humans, Vero Cells, Campylobacter jejuni, CHO Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review